The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...

Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...

Here are some studies from just the last couple of weeks — all funded in part by the NIH — that could advance the biopharma ...

An experimental mRNA vaccine boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers ...

The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...

Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 percent higher in participants who were aged 65 years or older. Previous trial ...